Private company

Meiji Seika Pharma

Logo: Meiji, Public domain, via Wikimedia Commons3

Japanese food and pharmaceutical company

Meiji Seika Pharma Co., Ltd. (Meiji Seikaファルマ株式会社, Meiji Seika Faruma Kabushiki gaisha), formerly Meiji Seika Kaisha, Ltd.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Oct 9, 1916Founded1

Meiji Seika Pharma Co., Ltd. (Meiji Seikaファルマ株式会社, Meiji Seika Faruma Kabushiki gaisha), formerly Meiji Seika Kaisha, Ltd.2

Acquisitions

  1. Succeeded Meiji Seika1

Timeline

  1. Oct 9, 1916Founded Founded1

Calendar

Drug trials and FDA: recently

  1. Nov 22, 2024Phase 3 trial completed Phase 3 trial of co-administration of cefepime and nacubactam, co-administration of aztreonam and nacubactam and others in Complicated Urinary Tract Infection: primary completion Nov 22, 2024, results posted Nov 25, 2025 (ClinicalTrials.gov NCT05887908).4

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar